Titan Pharmaceuticals, Inc. is a development-stage biotechnology company based in El Cerrito, CA. They specialize in the development of proprietary therapeutics using their clinically proven ProNeura long-term, continuous drug delivery technology. Their innovative drug delivery platform, ProNeura, delivers low-dose, non-fluctuating medication levels for up to one year following a single subdermal insertion procedure, making it ideal for the treatment of select chronic diseases. With a focus on maintaining consistent, around-the-clock blood levels of medication, Titan Pharmaceuticals aims to improve medical outcomes and benefit patients with various chronic conditions.
Titan Pharmaceuticals is currently advancing their product pipeline, which includes the development of Kappa Opioid Receptor Agonist TP-2021 Implant for the treatment of moderate-to-severe chronic pruritus and Nalmefene Implant for the prevention of relapse in OUD patients following detoxification from opioids. Their ProNeura technology has the potential to revolutionize the treatment of chronic diseases by providing stable blood levels of medication over an extended period. As a company committed to innovation in medicine, Titan Pharmaceuticals is dedicated to improving the health and lives of patients through their cutting-edge drug delivery technology.
Generated from the website